InsiderTrades

Form 4 for TXG 10x Genomics, Inc.

Accepted 2023-06-16 00:00:00 ET · period of report 2023-06-14 · accession 0001610717-23-000177 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-06-16 2023-06-14 TXG ROBERTS BRYAN E Dir A - Grant $0.00 +1,865 88.5K +2% $0
D 2023-06-16 2023-06-14 TXG ROBERTS BRYAN E Dir A - Grant $0.00 +4,661 4,661 New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2023-06-14 A A 1,865 $0.00 88,503 D — — (F1) Constitute restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/4th of the RSUs shall vest on each quarterly anniversary measured from May 21, 2023, subject to the Reporting Person continuing as a service provider through each such date. (F3) The Reporting Person is a member of the Management Company. Under an agreement between the Reporting Person and the Management Company, the Reporting Person is deemed to hold the reported shares for the sole benefit of the Management Company and must exercise the reported shares solely upon the direction of the Management Company, which is entitled to the shares. The Management Company may be deemed the indirect beneficial owner of the reported shares, and the Reporting Person may be deemed the indirect beneficial owner of the reported shares through his interest in the Management Company. The Reporting Person disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein. (F2) Represents (a) 83,893 shares of Class A common stock held directly by the Reporting Person and (b) 4,610 shares of Class A common stock held on behalf of VR Management, LLC (the "Management Company").
2 Derivative Stock Option (right to buy) 2023-06-14 A A 4,661 $0.00 4,661 D $57.62 · — to 2033-06-14 4,661 Class A Common Stock (F3) The Reporting Person is a member of the Management Company. Under an agreement between the Reporting Person and the Management Company, the Reporting Person is deemed to hold the reported shares for the sole benefit of the Management Company and must exercise the reported shares solely upon the direction of the Management Company, which is entitled to the shares. The Management Company may be deemed the indirect beneficial owner of the reported shares, and the Reporting Person may be deemed the indirect beneficial owner of the reported shares through his interest in the Management Company. The Reporting Person disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein. (F6) 1/12th of the total number of shares subject to the option vest on each monthly anniversary measured from June 14, 2023, subject to the Reporting Person continuing as a service provider through each such date.